TL;DR: Magnesium L-threonate (Magtein) was engineered at MIT to cross the blood-brain barrier and is the only form with direct evidence for raising brain magnesium and improving cognitive performance. Magnesium glycinate is a highly bioavailable, well-tolerated form whose glycine component acts as an inhibitory neurotransmitter co-agonist, delivering meaningful calming and sleep benefits. Threonate is the better choice for targeted cognitive enhancement; glycinate is the better choice for sleep, anxiety, and general magnesium repletion. For many people, using both is the most effective strategy.
Introduction
If you have spent any time researching magnesium supplements for brain health, you have almost certainly encountered the same question: should I take magnesium L-threonate or magnesium glycinate? Both are routinely recommended as “brain-friendly” forms of magnesium. Both are well-absorbed. Both appear in the inventories of serious biohackers, neurologists, and functional medicine practitioners. And both cost meaningfully more than the magnesium oxide tablets gathering dust on pharmacy shelves.
But they are not interchangeable. They work through different mechanisms, they have different evidence profiles, they deliver different amounts of elemental magnesium, and they are best suited for different goals. The difference matters, and understanding it can save you money, improve your outcomes, and help you build a supplementation strategy that actually aligns with what you are trying to achieve.
This article is a direct, evidence-based comparison. We will cover the science behind each form, the key research, a head-to-head comparison across the variables that matter, practical dosing, cost considerations, and guidance on when to use one, the other, or both. For a broader overview of magnesium’s role in cognitive function — including NMDA receptor regulation, the deficiency epidemic, food sources, and a comparison of all major supplement forms — see our comprehensive guide on magnesium and brain health.
Magnesium L-Threonate: The Brain-Targeted Form
Origin: The MIT Research
Magnesium L-threonate exists because of a specific scientific problem. By the mid-2000s, researchers had established that increasing magnesium concentration in the brain could enhance synaptic plasticity, boost NMDA receptor function, and improve memory in animal models. The challenge was that conventional magnesium supplements — oxide, citrate, chloride, and others — could raise serum magnesium levels but failed to meaningfully increase magnesium concentrations in the brain or cerebrospinal fluid. The blood-brain barrier tightly regulates magnesium transport, and simply flooding the bloodstream with the mineral did not translate to higher levels where it mattered most.
Guosong Liu and colleagues at MIT and Tsinghua University set out to solve this problem. They systematically screened multiple magnesium compounds for their ability to increase intracellular magnesium in neuronal cultures. The breakthrough was the discovery that L-threonate — a metabolite of vitamin C — served as an exceptionally effective carrier molecule. When magnesium was chelated with L-threonate, the resulting compound (magnesium L-threonate, or MgT) demonstrated markedly superior uptake into neurons compared to other forms.
The Slutsky et al. (2010) Study
The landmark paper was published in Neuron in 2010 by Slutsky, Abumaria, Wu, and Liu. This study remains the foundational piece of evidence for magnesium L-threonate and has been cited over 500 times. The key findings:
Brain magnesium elevation. Oral MgT supplementation increased cerebrospinal fluid magnesium levels in rats by approximately 15 percent. Other magnesium compounds tested at equivalent doses failed to achieve this increase. This was the critical finding — MgT could do what other forms could not.
Increased synapse density. MgT-treated rats showed measurably higher density of functional synapses in the hippocampus (the brain’s memory center) and the prefrontal cortex (the seat of executive function and working memory). These structural changes were confirmed through both electrophysiological recordings and anatomical analysis.
Improved memory across age groups. On behavioral tests including novel object recognition, T-maze alternation, and fear conditioning, MgT-treated animals outperformed controls. Crucially, benefits were observed in both young adult and aged rats, though the magnitude of improvement was greater in older animals — consistent with the idea that age-related magnesium decline creates a larger window for supplementation to help.
Enhanced NMDA receptor signaling. Long-term potentiation (LTP), the cellular mechanism of learning, was significantly enhanced in treated animals. This aligned perfectly with the known role of magnesium in NMDA receptor gating: more magnesium in the synaptic environment means better signal-to-noise ratio at NMDA receptors, which means more precise and robust synaptic strengthening.
Human Evidence: Liu et al. (2016)
The animal data would mean little without human follow-up. In 2016, Liu and colleagues published results from a randomized, double-blind, placebo-controlled trial in the Journal of Alzheimer’s Disease. The study enrolled adults aged 50 to 70 with subjective cognitive complaints — people who felt their memory and mental sharpness were declining, a population at elevated risk for future dementia.
Participants received either the proprietary MgT formulation (marketed as Magtein or MMFS-01, providing approximately 144 mg of elemental magnesium per day) or placebo for 12 weeks. The treatment group showed statistically significant improvements on a composite of cognitive tests assessing executive function and working memory. Perhaps the most striking finding: the researchers estimated that cognitive performance in the MgT group was “rejuvenated” by approximately nine years relative to baseline — meaning their test scores shifted to levels typical of people roughly a decade younger.
Important caveats apply. The study was modest in size, it was funded by the company commercializing MgT, and the nine-year “brain age reversal” figure — while attention-grabbing — is an estimate derived from modeling, not a direct biological measurement. Independent replications with larger sample sizes are still needed. Nevertheless, the effect sizes were substantial enough to be taken seriously, and the biological mechanism linking MgT to cognitive improvement is well-established from the preclinical work.
Mechanism Summary
Magnesium L-threonate works primarily by getting magnesium into the brain more effectively than other forms. Once there, magnesium enhances NMDA receptor gating (improving the signal-to-noise ratio for synaptic plasticity), increases synapse density, supports long-term potentiation, and provides neuroprotection against excitotoxicity. The L-threonate carrier itself does not appear to have significant independent neurological effects — its value lies in its transport properties.
Magnesium Glycinate: The Calming Workhorse
Bioavailability and Absorption
Magnesium glycinate (also called magnesium bisglycinate) is a chelated form in which magnesium is bound to two molecules of the amino acid glycine. This chelation is important for absorption: the glycine molecules protect the magnesium from binding to phytates, oxalates, and other compounds in the gut that would otherwise reduce absorption. The result is consistently high bioavailability with minimal gastrointestinal side effects — no osmotic laxative effect, no cramping, and no loose stools, even at relatively high doses.
This makes glycinate one of the most practical forms for achieving and maintaining adequate total body magnesium levels. For the roughly 48 percent of U.S. adults consuming less magnesium than the Estimated Average Requirement (Rosanoff et al., 2012), glycinate offers a reliable and well-tolerated path to repletion.
Glycine: The Hidden Advantage
What sets magnesium glycinate apart from other well-absorbed forms is its glycine content. Glycine is not merely a passive carrier — it is a bioactive amino acid with significant effects on the nervous system.
Inhibitory neurotransmitter. Glycine is one of the major inhibitory neurotransmitters in the central nervous system, particularly in the brainstem and spinal cord. It binds to glycine receptors (chloride channels) and produces inhibitory, calming effects on neural activity.
NMDA receptor co-agonist. In a complementary role, glycine also serves as a co-agonist at NMDA receptors — meaning it is required, alongside glutamate, for NMDA receptor activation. This is a nuanced contribution: glycine helps NMDA receptors function properly without driving excessive excitation, and adequate glycine levels support healthy synaptic plasticity.
Sleep quality. Glycine’s effects on sleep are supported by direct clinical evidence. Bannai et al. (2012) conducted a randomized, double-blind, placebo-controlled study published in Frontiers in Neurology examining the effects of 3 grams of glycine taken before bedtime. Participants reported improved subjective sleep quality, reduced time to fall asleep, and decreased daytime sleepiness. Glycine appears to lower core body temperature — a key physiological trigger for sleep onset — by promoting vasodilation in peripheral blood vessels. Inagawa et al. (2006) confirmed this thermoregulatory mechanism in a separate study published in Sleep and Biological Rhythms.
Stress and calming effects. Glycine modulates the stress response through multiple pathways. It dampens excitatory neurotransmission, supports GABA function, and has been shown to reduce markers of physiological stress. When combined with magnesium — which independently promotes GABAergic tone and suppresses cortisol — the calming effect is compounded.
A standard dose of magnesium glycinate providing 200 mg of elemental magnesium delivers approximately 1,400 mg of glycine — not quite the 3,000 mg used in the dedicated glycine sleep studies, but a meaningful amount that contributes to the overall calming profile of this form.
Clinical Use Profile
Magnesium glycinate is the most broadly prescribed magnesium form by integrative and functional medicine practitioners, and for good reason. It addresses the most common reasons people supplement with magnesium: correcting dietary insufficiency, improving sleep, reducing anxiety, supporting muscle relaxation, and managing stress — all with excellent tolerability. It lacks the targeted brain-penetration evidence of threonate, but its combination of high bioavailability, glycine co-benefits, and low side effect profile makes it the most versatile magnesium supplement available.
Head-to-Head Comparison
The following table summarizes the key differences across the variables that matter most for practical decision-making:
| Feature | Magnesium L-Threonate | Magnesium Glycinate |
|---|---|---|
| Elemental Mg per dose | ~144 mg (from ~2,000 mg compound) | ~200–400 mg (from ~1,400–2,800 mg compound) |
| Elemental Mg by weight | ~8% | ~14% |
| Blood-brain barrier penetration | Demonstrated (Slutsky et al., 2010) | Not specifically demonstrated |
| Cognitive evidence | Direct (animal + human RCT) | Indirect (via glycine co-agonism and sleep improvement) |
| Sleep evidence | Possible (via central effects) | Strong (magnesium + glycine thermoregulation) |
| Calming / anxiolytic effects | Moderate | Strong (magnesium + glycine inhibitory effects) |
| GI tolerance | Good | Excellent (best among all forms) |
| Cost per month (typical) | $25–45 USD | $10–20 USD |
| Best primary use case | Cognitive enhancement, memory support, age-related decline | Sleep, anxiety, general repletion, stress management |
| Typical dosing | 1,500–2,000 mg compound/day (2 doses) | 400–800 mg compound/day providing 200–400 mg elemental Mg |
| Carrier molecule activity | L-threonate: transport function, no major independent neuroactivity | Glycine: inhibitory neurotransmitter, NMDA co-agonist, sleep promoter |
When to Use Each Form
Choose Magnesium L-Threonate When:
Cognitive performance is your primary goal. If you are specifically trying to improve memory, executive function, or mental clarity — particularly if you are over 40 and noticing age-related changes — threonate has the strongest mechanistic and clinical rationale. It is the only magnesium form with published evidence for increasing brain magnesium concentrations and improving cognitive test scores.
You are concerned about age-related cognitive decline. The Liu et al. (2016) trial specifically enrolled older adults with subjective cognitive complaints and showed meaningful improvement. If you are in that demographic, threonate is the most evidence-aligned choice.
You are already addressing general magnesium needs through diet or another supplement. Threonate provides relatively little elemental magnesium (~144 mg/day at standard dosing). If your diet is already rich in magnesium or you are taking another well-absorbed form for general repletion, threonate can serve as a targeted brain-specific add-on.
Choose Magnesium Glycinate When:
Sleep is your primary concern. The combination of well-absorbed magnesium (which promotes GABAergic tone and reduces cortisol) with glycine (which promotes sleep onset through peripheral vasodilation and core temperature reduction) makes glycinate the optimal magnesium form for sleep quality. If poor sleep is undermining your cognitive function — and it very often is — glycinate addresses the root cause directly.
You need to correct a magnesium deficit. With approximately 14 percent elemental magnesium by weight, glycinate delivers substantially more magnesium per gram of supplement than threonate (8 percent). It is the more efficient choice for addressing the widespread subclinical magnesium inadequacy affecting nearly half of adults in the developed world.
Anxiety or stress is a significant issue. The dual calming action of magnesium and glycine makes this form particularly effective for individuals dealing with chronic anxiety, heightened stress reactivity, or difficulty relaxing. Boyle, Lawton, and Dye (2017) found in their systematic review in Nutrients that magnesium supplementation reduced subjective anxiety in anxiety-prone individuals.
Cost matters. Magnesium glycinate typically costs 40 to 60 percent less than threonate per month. For individuals on a budget who need a single form that covers the most ground, glycinate offers the best value.
Combine Both When:
You want comprehensive coverage. The two forms are complementary, not redundant. Threonate targets the brain specifically; glycinate handles whole-body repletion, sleep, and calming. Using both addresses the full spectrum of magnesium-related cognitive and neurological goals.
You are optimizing cognitive function seriously. If cognitive performance is a genuine priority — whether for professional reasons, academic work, or healthy aging — the combination of brain-targeted magnesium delivery (threonate) with optimized sleep architecture (glycinate) is a well-reasoned protocol. Sleep is when the brain consolidates memories, clears metabolic waste via the glymphatic system, and rebalances neurotransmitter systems — processes that are also profoundly shaped by what you eat throughout the day. Improving both the raw material supply (brain magnesium) and the recovery process (sleep quality) compounds the benefits.
Practical Dosing Protocol
Magnesium L-Threonate
The dose used in the Liu et al. (2016) human trial was approximately 1,500 to 2,000 mg of the compound per day, providing roughly 144 mg of elemental magnesium. Most commercial products (including the branded Magtein formulation) recommend splitting this into two doses:
- Morning dose: 1,000 mg of the compound (approximately 72 mg elemental Mg)
- Evening dose: 1,000 mg of the compound (approximately 72 mg elemental Mg)
Some users find the evening dose promotes relaxation and sleep onset, while others prefer to take the full dose earlier in the day. Individual response varies; experimentation is reasonable.
Magnesium Glycinate
For general repletion and sleep support:
- 200 to 400 mg of elemental magnesium per day, taken in the evening, ideally one to two hours before bed.
- This corresponds to approximately 1,400 to 2,800 mg of the magnesium glycinate compound.
- Glycinate is well tolerated even at the higher end of this range and rarely causes gastrointestinal distress.
Combined Protocol
A practical combination protocol for someone pursuing both cognitive and sleep goals:
- Morning: Magnesium L-threonate, 1,000 mg compound (~72 mg elemental Mg)
- Evening (1–2 hours before bed): Magnesium L-threonate, 1,000 mg compound (~72 mg elemental Mg) + magnesium glycinate, 200 mg elemental Mg
This provides a total of approximately 344 mg of elemental magnesium from supplements, which — combined with dietary intake from magnesium-rich foods — should comfortably meet or exceed the RDA for most adults. The total remains within safe limits; the Tolerable Upper Intake Level of 350 mg/day for supplemental magnesium was set based on poorly absorbed forms (oxide, citrate) and their laxative effects. Chelated forms like threonate and glycinate are generally well tolerated above this threshold.
Cost Analysis
Cost is a legitimate consideration, particularly for supplements taken daily over months or years.
Magnesium L-threonate is the more expensive option. A 30-day supply of a quality threonate product (providing the standard 2,000 mg compound/day) typically costs between $25 and $45 USD, depending on brand and sourcing. Branded Magtein products tend to sit at the higher end of this range; generic magnesium L-threonate formulations have entered the market at lower price points, though quality and consistency may vary.
Magnesium glycinate is substantially cheaper. A 30-day supply providing 200 to 400 mg of elemental magnesium per day typically costs $10 to $20 USD. This reflects both the simpler manufacturing process and the larger market for this form.
Combined monthly cost: Approximately $35 to $65 USD for both forms together. For context, this is roughly comparable to a moderate coffee habit and considerably less than most prescription medications for cognitive or sleep complaints.
If budget forces a choice between the two, the decision should be guided by your primary goal. If cognition is the priority, invest in threonate. If sleep and general magnesium status are the priority, glycinate delivers excellent results at the lower price point.
Common Misconceptions
“Glycinate crosses the blood-brain barrier too”
This claim appears frequently in supplement marketing but is misleading. All forms of magnesium contribute to serum magnesium levels, and serum magnesium does influence brain magnesium to some degree. However, glycinate has no published evidence demonstrating that it increases brain or cerebrospinal fluid magnesium concentrations above what would be expected from serum-level changes alone. Threonate’s uniqueness lies in its demonstrated ability to increase brain magnesium beyond what serum elevation alone predicts — a difference that is mechanistically meaningful, not merely theoretical.
“You only need one form”
For many people, a single well-chosen form is adequate. But the two forms serve different functions, and for those pursuing comprehensive cognitive optimization, combining them is neither redundant nor wasteful. Threonate targets the brain; glycinate targets whole-body repletion and sleep. These are different jobs.
“Magnesium oxide is just as good if you take enough”
No. Magnesium oxide has approximately 4 to 5 percent absorption (Firoz and Graber, 2001). Increasing the dose does not overcome poor bioavailability — it simply increases the amount that remains in the gut, causing osmotic diarrhea. Neither oxide nor citrate has evidence for meaningful cognitive effects. This is a case where form matters as much as dose.
Practical Takeaway
Match the form to your primary goal. Magnesium L-threonate is the evidence-based choice for cognitive enhancement, memory support, and age-related brain health. Magnesium glycinate is the evidence-based choice for sleep quality, anxiety reduction, and efficient whole-body magnesium repletion.
Consider combining both forms for comprehensive coverage. Threonate in the morning and evening for brain-targeted delivery, plus glycinate in the evening for sleep and systemic repletion, is a well-reasoned protocol supported by the mechanisms and evidence for each.
Prioritize glycinate if budget is limited. It delivers more elemental magnesium per dollar, supports sleep (which is itself foundational to cognitive function), and addresses the subclinical magnesium deficiency affecting nearly half the adult population.
Prioritize threonate if cognitive decline is your specific concern. The Slutsky et al. (2010) and Liu et al. (2016) research provides a mechanistic and clinical rationale that no other magnesium form can match for this particular goal.
Take glycinate in the evening for maximum sleep benefit. One to two hours before bed allows the magnesium and glycine to promote relaxation, lower core body temperature, and support sleep onset.
Do not neglect dietary magnesium. Supplements are most effective when layered on top of a diet rich in pumpkin seeds, almonds, dark leafy greens, legumes, and whole grains — foods that also feature prominently in the Mediterranean diet, the best-supported overall dietary pattern for brain health. No supplement fully replaces food-based intake.
Give it time. Sleep benefits from glycinate may appear within one to two weeks. Cognitive benefits from threonate, based on the Liu et al. (2016) trial, emerged over six to twelve weeks. Patience and consistency matter more than dose escalation.
Frequently Asked Questions
Can I take magnesium L-threonate and glycinate at the same time?
Yes. There is no interaction between the two forms, and they are commonly taken together. Many practitioners specifically recommend the combination: threonate for brain-targeted magnesium delivery and glycinate for sleep and overall repletion. The total elemental magnesium from a combined protocol (approximately 300 to 350 mg from supplements) is safe for individuals with normal kidney function.
Which form is better for sleep?
Magnesium glycinate is the stronger choice for sleep. It combines well-absorbed magnesium (which supports GABAergic tone and reduces cortisol) with glycine, an amino acid with direct evidence for improving sleep quality through thermoregulatory mechanisms (Bannai et al., 2012; Inagawa et al., 2006). Threonate may also improve sleep through its central nervous system effects, but glycinate’s dual mechanism makes it the more targeted option for this specific goal.
Is Magtein the same as magnesium L-threonate?
Magtein is the branded, patented form of magnesium L-threonate developed by the research team behind the original Slutsky et al. (2010) study. It is the specific formulation (also designated MMFS-01) used in the Liu et al. (2016) human clinical trial. Generic magnesium L-threonate products contain the same compound but may differ in purity, manufacturing standards, or excipients. Magtein products typically cost more but offer the assurance that the formulation matches what was tested in the clinical research.
How long does magnesium L-threonate take to work?
In the Liu et al. (2016) trial, significant cognitive improvements were detectable by week six and continued through week twelve. Anecdotal reports vary — some users describe subjective improvements in mental clarity within two to three weeks, while others notice changes more gradually. A minimum commitment of six to eight weeks at the standard dose is reasonable before evaluating whether the supplement is working for you.
Can magnesium glycinate cause drowsiness during the day?
At standard doses (200 to 400 mg elemental magnesium), daytime drowsiness is uncommon. Glycine’s calming effects are real but generally subtle at the amounts delivered by a magnesium glycinate supplement. If daytime drowsiness occurs, shift the full dose to the evening. Some individuals who are particularly sensitive to glycine’s inhibitory effects may prefer to take glycinate exclusively before bed and use threonate or another form during the day.
Is magnesium L-threonate safe long-term?
No safety concerns have been identified with long-term use at standard doses. The Liu et al. (2016) trial reported no significant adverse effects over 12 weeks. Magnesium L-threonate provides a modest amount of elemental magnesium (approximately 144 mg/day), well within safe limits. L-threonate itself is a naturally occurring metabolite of vitamin C and is not known to accumulate or cause toxicity. As with any supplement, individuals with kidney disease should consult their physician before use, as impaired renal function affects magnesium excretion.
Sources
Slutsky, I., Abumaria, N., Wu, L. J., Bhatt, I., Bhatt, C. P., Bhatt, D. H., … & Liu, G. (2010). Enhancement of learning and memory by elevating brain magnesium. Neuron, 65(2), 165-177.
Liu, G., Weinger, J. G., Lu, Z. L., Xue, F., & Sadeghpour, S. (2016). Efficacy and safety of MMFS-01, a synapse density enhancer, for treating cognitive impairment in older adults: a randomized, double-blind, placebo-controlled trial. Journal of Alzheimer’s Disease, 49(4), 971-990.
Bannai, M., Kawai, N., Ono, K., Nakahara, K., & Murakami, N. (2012). The effects of glycine on subjective daytime performance in partially sleep-restricted healthy volunteers. Frontiers in Neurology, 3, 61.
Inagawa, K., Hiraoka, T., Kohda, T., Yamadera, W., & Takahashi, M. (2006). Subjective effects of glycine ingestion before bedtime on sleep quality. Sleep and Biological Rhythms, 4(1), 75-77.
Rosanoff, A., Weaver, C. M., & Rude, R. K. (2012). Suboptimal magnesium status in the United States: are the health consequences underestimated? Nutrition Reviews, 70(3), 153-164.
Boyle, N. B., Lawton, C., & Dye, L. (2017). The effects of magnesium supplementation on subjective anxiety and stress — a systematic review. Nutrients, 9(5), 429.
Firoz, M., & Graber, M. (2001). Bioavailability of US commercial magnesium preparations. Magnesium Research, 14(4), 257-262.
Abbasi, B., Kimiagar, M., Sadeghniiat, K., Shirazi, M. M., Hedayati, M., & Rashidkhani, B. (2012). The effect of magnesium supplementation on primary insomnia in elderly: a double-blind placebo-controlled clinical trial. Journal of Research in Medical Sciences, 17(12), 1161-1169.
Held, K., Antonijevic, I. A., Kunzel, H., Uhr, M., Wetter, T. C., Golly, I. C., … & Murck, H. (2002). Oral Mg(2+) supplementation reverses age-related neuroendocrine and sleep EEG changes in humans. Pharmacopsychiatry, 35(4), 135-143.